Cite
APA Citation
Ferrante, M., Panes, J., Baert, F., Louis, E., Kaser, A., Gustafson, D., Hall, D., Böcher, W., Herichova, I., Liao, X., Wallace, K., Kalabic, J., & D'Haens, G. (2019). oWE-05 Interim long-term safety/efficacy of risankizumab treatment in crohn's disease patients from the open-label extension study. Gut, 68(2), A64. http://access.bl.uk/ark:/81055/vdc_100135151977.0x000042